Risk-adapted adjuvant therapy of luminal early breast cancer in 2020-Reference-Cited by-同舟云学术

Risk-adapted adjuvant therapy of luminal early breast cancer in 2020

Published:2020-12-15 Issue:1 Volume:33 Page:53-58
ISSN:1040-872X
Container-title:Current Opinion in Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Harbeck Nadia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynaecology

Reference22 articles.

1. Breast Cancer;Harbeck;Nat Rev Dis Primers,2019

2. First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer;Ettl;Arch Gynecol Obstet,2020

3. Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results;Noske;Breast,2020

4. West German Study Group Phase III PlanB Trial: first prospective outcome data for the 21-gene recurrence score assay and concordance of prognostic markers by central and local pathology assessment;Gluz;J Clin Oncol,2016

5. Breast Cancer Index predicts extended endocrine benefit to individualize selection of HR+ early stage breast cancer patients for 10 years of endocrine therapy;Noordhoek;Clin Cancer Res,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Metabolomics and Transcriptomics Analysis of Anacardic Acid Inhibition of Breast Cancer Cell Viability;International Journal of Molecular Sciences;2024-06-27

2. Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patient Records Analysis;JMIR Formative Research;2024-03-21

3. Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patient Records Analysis (Preprint);2023-07-24

4. Correlation Analysis of Pathological Features and Axillary Lymph Node Metastasis in Patients with Invasive Breast Cancer;Journal of Immunology Research;2022-09-19

5. Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany;Archives of Gynecology and Obstetrics;2021-09-07